We all know the sobering statistics: approximately 42% of adults in the U.S. currently have obesity1 and that number is expected to rise to 1 in 2 adults by 2030.

According to a recent survey by Business Group on Health, 92% of large employers say they are concerned about high drug costs as a larger driver of healthcare cost trends.

New and highly promising GLP-1 medications could be game changers, but in the scramble to get these treatments to as many people as possible, many in digital health are missing the big picture.

Dr. Peter Antall, former Amwell CMO, joins Lark as Chief Medical Officer and President, Medical Networks as part of clinical expansion.

As the demand for GLP-1 medications continues to soar, health plans and employers must develop a weight management strategy that balances the clinical indications with the financial implications.

While it’s always tricky to figure out which trends are sustainable and which ones will fade, here are a few we think are going to stick around for the long run.

We are delighted to announce the results of our latest 2023 clinical studies.

Get to know Magnus Hedemark, Lark's new VP of Engineering, through reading his interview.

A recap of the ViVE 2023 conference and which healthcare topic stood out amongst the rest.

Pilot study reveals digital coaching with educational resources and remote patient monitoring helps increase confidence in improving and managing heart health

Lark is a personalized virtual coach available 24/7 on your smartphone. Lark partners with leading insurance brands to bring you chronic condition prevention and management at no cost if eligible.

Lark Health's latest published research shows the clinical effectiveness of its digital Diabetes Prevention and Hypertension Management programs.